More money is being funneled into science based startups, especially fledgling companies in the biotech sector.
A report in The New York Times by Hiroko Tabuchi explained that “investments in biotechnology start-ups rose 26 percent in the first half of 2014, to $2.93 billion, from the period a year earlier and is on track to exceed the 2008 peak of $5.14 billion.”
Tabuchi writes that a possible explanation for this uptick in funding for science startups is a “growing feeling” among investors that Silicon Valley’s best and brightest are steering clear of the world’s biggest problems.
Founders Fund, the venture capital firm started by legendary investor Peter Thiel, echoes this sentiment with this company motto: “We wanted flying cars, instead we got 140 characters.”
“We’ve had enormous progress in the world of bits, but not as much in the world of atoms,” Thiel told Fortune Magazine in an interview.
Now, this deluge of capital brought attention to numerous innovative companies last year.
Here are five biotech startups to watch in 2015.